Himadri Speciality Chemical Reports Record FY26 Performance with Strong Q4 Growth

6 min read     Updated on 04 May 2026, 11:25 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Himadri Speciality Chemical Ltd delivered its strongest financial performance in FY26, achieving record consolidated EBITDA of INR 1,006 crores and PAT of INR 755 crores. Q4 FY26 showed robust growth with revenue of INR 1,288 crores, EBITDA of INR 280 crores, and PAT of INR 208 crores. The company commissioned its first anode material facility, expanded speciality carbon black capacity to 130,000 metric tons, and made strategic investments in battery technology partnerships including IBC and Sicona.

powered bylight_fuzz_icon
39294494

*this image is generated using AI for illustrative purposes only.

Himadri Speciality Chemical Ltd delivered its strongest financial performance to date in FY26, achieving record consolidated EBITDA of INR 1,006 crores and profit after tax of INR 755 crores. The company reported consolidated revenue of INR 4,661 crores for the full year, with EBITDA growing approximately 19% year-on-year from INR 847 crores in FY25. PAT increased 36% compared to INR 555 crores in the previous year, reflecting the strength of its value-added portfolio and operational discipline.

For the fourth quarter of FY26, consolidated revenue stood at INR 1,288 crores, representing a 14% increase compared to INR 1,135 crores in the corresponding period of the previous year. Q4 EBITDA reached INR 280 crores, registering 21% year-on-year growth, while PAT stood at INR 208 crores, delivering strong growth of approximately 34% year-on-year. On a standalone basis, FY26 revenue was INR 4,405 crores with EBITDA of INR 978 crores and PAT of INR 750 crores.

Strategic Developments and Capacity Expansion

The company achieved a significant milestone in its lithium-ion battery materials strategy by commissioning its first anode material manufacturing facility at Mahistikry, West Bengal, on 23 April 2026. The facility has an initial capacity of 200 metric tons per annum, with the entire technology platform developed in-house. During the year, the company invested INR 120 crores in research and development.

The speciality carbon black capacity expansion progressed with the successful commissioning of an additional 70,000 metric ton facility at Mahistikry, taking total speciality carbon black capacity to 130,000 metric tons per annum and overall carbon black capacity to 250,000 metric tons per annum. The Mahistikry facility is now the world's single largest location for speciality carbon black production. Additionally, coal-tar pitch distillation capacity was debottlenecked to 600,000 metric tons per annum.

Lithium-Ion Battery Materials Strategy

Execution of Phase 1 of the lithium-ion phosphate cathode active material project is on track, with a total envisaged capacity of 40,000 metric tons per annum. The first milestone capacity of 2,000 metric tons is targeted for commissioning by Q3 FY27, with the balance Phase 1 capacity to be progressively commissioned over the subsequent 12 months. FY29 is envisaged as the year for full Phase 1 operations. The total capex for the 40,000 metric ton capacity is INR 1,125 crores.

Beyond Phase 1, the company aims to build a globally relevant LFP platform with the capability to produce 200,000 metric tons of LFP cathode active material. This positions Himadri as the first company globally to establish commercial-scale LFP cathode-active material manufacturing facility outside China. The company has also made strategic investments in IBC, International Battery Company, and secured exclusive technology licensing rights for Sicona's silicon-carbon anode technology.

Strategic Partnerships and Collaborations

The collaboration with Sicona Battery Technologies has progressed significantly during the year, with Sicona achieving important milestones at pilot scale level. Further capacity expansion is targeted for completion by Q2 FY27. Sicona's Gen3 SiCx® material has demonstrated superior energy density and improved electrochemical characteristics, while Gen4 SiCx® has shown high-capacity retention over extended cycle life.

The strategic investment in IBC, International Battery Company, a U.S. headquarter developer and manufacturer of chemistry-agnostic prismatic lithium-ion cells, enables real-world validation and early commercial deployment of Himadri's lithium-ion battery materials. IBC operates across diversified end-use applications including B2B fleet customers, two and three-wheeler OEMs, and global battery exports for energy storage and mobility solutions. The collaboration with Invati Creations continues to progress steadily with focused research efforts underway across advanced lithium-ion electrode materials.

Birla Tyres Revival and Financial Health

Birla Tyres, which marked its first half year of operations in FY26, contributed INR 187 crores in revenue. The company expects this business to reach INR 3,000 crores of top line over the next four years. The revival strategy has prioritised product-market fit, channel strength, and brand repositioning before pursuing volume-led growth. The distributor network has expanded to 43 distributors and over 1,000 dealers.

The company maintains a resilient balance sheet with a net positive cash balance of INR 121 crores as of 31 March 2026. Return on capital employed reached 32% in FY26. Management has committed to doubling PAT to INR 1,100 crores by FY28. Over the last five years on a consolidated basis, revenues have grown at a CAGR of 14%, EBITDA at 58%, and profit after tax at 110%.

Financial Performance Summary

Metric Q4 FY26 FY26
Consolidated Revenue INR 1,288 crores INR 4,661 crores
Consolidated EBITDA INR 280 crores INR 1,006 crores
Consolidated PAT INR 208 crores INR 755 crores
Standalone Revenue INR 1,101 crores INR 4,405 crores
Standalone EBITDA INR 252 crores INR 978 crores
Standalone PAT INR 186 crores INR 750 crores

The company expects to achieve around 85%-90% capacity utilization for newly announced capacities in FY27. Himadri has been awarded Platinum rating by EcoVadis for the second consecutive year, placing it among the top 1% of companies globally among 150,000 rated by EcoVadis. The company's geographic presence expanded from 56 countries to 61 countries during the year. The anthraquinone and carbazole project is progressing as planned and expected to commission in Q2 FY27.

Source: None/Company/INE019C01026/4041d1df071347c6.pdf

Historical Stock Returns for Himadri Speciality Chemical

1 Day5 Days1 Month6 Months1 Year5 Years
-0.58%-4.85%+15.91%+33.28%+26.24%+1,081.39%

How quickly can Himadri secure customer approvals for its LFP cathode active material, and which domestic or global EV manufacturers are likely to be its anchor clients for Phase 1 capacity?

Given that Himadri aims to be the first company outside China with commercial-scale LFP cathode manufacturing, what regulatory, tariff, or supply chain advantages could India's PLI scheme provide to accelerate its global competitiveness?

With Birla Tyres targeting INR 3,000 crores in revenue over four years and PCR commissioning within 24 months, what level of capital expenditure and margin dilution should investors expect from this segment before it turns meaningfully profitable?

Himadri Speciality Chemical
View Company Insights
View All News
like16
dislike

Himadri Specialty Targets 20%+ EBITDA Margins with Self-Funded Growth Strategy

1 min read     Updated on 28 Apr 2026, 08:58 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Himadri Speciality Chemical has outlined its growth strategy focusing on maintaining EBITDA margins above 20% through capacity expansions and operational improvements. The company plans to use its own funds for future expansions to keep debt levels very low, demonstrating a conservative financial approach. Key developments include the Anthraquinone and Carbazole project scheduled for Q2 FY27 commissioning and a newly launched specialty carbon black facility with 70,000 metric tons capacity targeting 85-90% utilization in FY27.

powered bylight_fuzz_icon
38892047

*this image is generated using AI for illustrative purposes only.

Himadri Speciality Chemical has outlined its strategic growth trajectory, expressing strong confidence in maintaining EBITDA margins above 20% while anticipating further improvements through capacity expansions and operational enhancements. The company's optimistic outlook is backed by significant investments in new facilities and advanced manufacturing capabilities, with a clear commitment to maintaining financial discipline through self-funded growth.

Financial Strategy and Debt Management

The company has adopted a conservative financial approach, planning to use its own funds for future expansions to keep debt levels very low. This strategic decision reflects management's commitment to maintaining a strong balance sheet while pursuing growth opportunities in the specialty chemicals sector.

Financial Strategy: Details
EBITDA Margin Target: Above 20%
Funding Approach: Own Funds
Debt Strategy: Keep Levels Very Low
Growth Focus: Self-Funded Expansions

Key Project Developments

The company's Anthraquinone and Carbazole project continues to progress according to schedule, with commissioning planned for Q2 FY27. This strategic initiative represents a significant expansion into high-value specialty chemicals, positioning Himadri Speciality Chemical to capture growing market opportunities in these specialized segments.

Project Details: Specifications
Project Type: Anthraquinone and Carbazole
Commissioning Timeline: Q2 FY27
Status: On Track

Specialty Carbon Black Facility Operations

The newly launched specialty carbon black facility, with a capacity of 70,000 metric tons, represents a major milestone in the company's expansion strategy. Management has set ambitious targets for this facility, aiming to achieve capacity utilization levels between 85% to 90% in FY27.

Facility Parameters: Details
Capacity: 70,000 Metric Tons
Product: Specialty Carbon Black
Target Utilization FY27: 85% to 90%
Current Status: Newly Launched

Operational Outlook

Himadri Speciality Chemical's management demonstrates strong confidence in the company's ability to sustain EBITDA margins above 20%. This optimistic projection is supported by the company's strategic focus on high-margin specialty chemicals and the anticipated operational improvements from new manufacturing capacities. The company expects further margin improvements driven by enhanced operational efficiency and the contribution from new facilities coming online, all while maintaining conservative debt levels through self-funded expansion plans.

Historical Stock Returns for Himadri Speciality Chemical

1 Day5 Days1 Month6 Months1 Year5 Years
-0.58%-4.85%+15.91%+33.28%+26.24%+1,081.39%

How will the specialty carbon black market dynamics affect Himadri's ability to achieve 85-90% capacity utilization by FY27?

What potential risks could impact the Q2 FY27 commissioning timeline for the Anthraquinone and Carbazole project?

Will Himadri's self-funded growth strategy limit its ability to compete with leveraged competitors in rapid market expansion scenarios?

Himadri Speciality Chemical
View Company Insights
View All News
like15
dislike

More News on Himadri Speciality Chemical

1 Year Returns:+26.24%